rofecoxib has been researched along with Bone Cancer in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Previously, we reported that celecoxib, a cyclooxygenase-2 (COX-2) inhibitor, prevented lung metastases but did not affect tumor growth in a model of Ewing sarcoma." | 7.78 | Celecoxib inhibits invasion and metastasis via a cyclooxygenase 2-independent mechanism in an in vitro model of Ewing sarcoma. ( Barlow, M; Edelman, M; Glick, RD; Soffer, SZ; Steinberg, BM, 2012) |
| "In a prospective study, nine patients with osteoid osteoma were treated with a selective cyclooxygenase-2 inhibitor (rofecoxib)." | 7.72 | Effect of rofecoxib on pain caused by osteoid osteoma. ( Aguirre, MA; Carpintero-Benitez, P; Lluch, M; Serrano, JA, 2004) |
| "Thirteen patients with osteoid osteoma were enrolled in a prospective trial to test whether rofecoxib, a selective cyclooxygenase-2 inhibitor, is as effective for pain control as acetylsalicylic acid." | 5.09 | Cyclooxygenase-2 inhibitor for pain management in osteoid osteoma. ( Bottner, F; Grethen, C; Lindner, N; Roedl, R; Winkelmann, W; Wortler, K, 2001) |
| "Previously, we reported that celecoxib, a cyclooxygenase-2 (COX-2) inhibitor, prevented lung metastases but did not affect tumor growth in a model of Ewing sarcoma." | 3.78 | Celecoxib inhibits invasion and metastasis via a cyclooxygenase 2-independent mechanism in an in vitro model of Ewing sarcoma. ( Barlow, M; Edelman, M; Glick, RD; Soffer, SZ; Steinberg, BM, 2012) |
| "In a prospective study, nine patients with osteoid osteoma were treated with a selective cyclooxygenase-2 inhibitor (rofecoxib)." | 3.72 | Effect of rofecoxib on pain caused by osteoid osteoma. ( Aguirre, MA; Carpintero-Benitez, P; Lluch, M; Serrano, JA, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Walter, B | 1 |
| Rogenhofer, S | 1 |
| Vogelhuber, M | 1 |
| Berand, A | 1 |
| Wieland, WF | 1 |
| Andreesen, R | 1 |
| Reichle, A | 1 |
| Barlow, M | 1 |
| Edelman, M | 1 |
| Glick, RD | 1 |
| Steinberg, BM | 1 |
| Soffer, SZ | 1 |
| Carpintero-Benitez, P | 1 |
| Aguirre, MA | 1 |
| Serrano, JA | 1 |
| Lluch, M | 1 |
| Kasper, B | 1 |
| Ho, AD | 1 |
| Egerer, G | 1 |
| Bottner, F | 1 |
| Roedl, R | 1 |
| Wortler, K | 1 |
| Grethen, C | 1 |
| Winkelmann, W | 1 |
| Lindner, N | 1 |
2 trials available for rofecoxib and Bone Cancer
| Article | Year |
|---|---|
Modular therapy approach in metastatic castration-refractory prostate cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Capecitabine; Deoxycytidine; Dexamet | 2010 |
Cyclooxygenase-2 inhibitor for pain management in osteoid osteoma.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bone Neoplasms; Cyclooxygenase | 2001 |
3 other studies available for rofecoxib and Bone Cancer
| Article | Year |
|---|---|
Celecoxib inhibits invasion and metastasis via a cyclooxygenase 2-independent mechanism in an in vitro model of Ewing sarcoma.
Topics: Basement Membrane; Bone Neoplasms; Celecoxib; Cell Line, Tumor; Cell Movement; Cyclooxygenase 2; Cyc | 2012 |
Effect of rofecoxib on pain caused by osteoid osteoma.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Bone Neoplasms; Dose-Response Relationsh | 2004 |
A new therapeutic approach in patients with advanced sarcoma.
Topics: Adult; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cycl | 2005 |